MSOA has been climbing all day and closed up 68%.

MSOA just announced cost saving measures are to further increase profitability.

I will announce a new big pick tomorrow night, so keep an eye out for it.

MSOA * encouraging developments
My Social Income, Inc. is a 12-year-old company formerly named “InteleCom, Inc.”. In the past it provided value added telecommunications and technology products, including Internet Phone Service through its former wholly owned subsidiary called InteleFone, Inc. The VoIP service has since been expanded to cell phone usage, now its main focus.

QTWW * may get a correction
Quantum Fuel Systems Technologies Worldwide, Inc., a fully integrated alternative energy company, is a leader in the development and production of advanced propulsion systems, energy storage technologies, and alternative fuel vehicles. Quantum’s portfolio of technologies includes electronic controls, hybrid electric drive systems, hydrogen storage and metering systems and alternative fuel vehicle technologies that enable fuel efficient, low emission hybrid, plug-in hybrid electric, fuel cell, and alternative fuel vehicles. Quantum’s powertrain engineering, system integration, vehicle manufacturing, and assembly capabilities provide fast-to-market solutions to support the production of hybrid and plug-in hybrid, hydrogen-powered hybrid, fuel cell, natural gas, and specialty vehicles, as well as modular, transportable hydrogen refueling stations. Quantum’s customer base includes automotive OEMs, dealer networks, fleets, aerospace industry, military and other government entities, and other strategic alliance partners.

ACTC * staging a turnaround
Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The company’s cellular reprogramming involves in the development of therapies based on the use of genetically identical pluripotent stem cells generated by its cellular reprogramming technologies. It is also generating stable cell lines with particular focus on retinal pigment epithelium cells and hemangioblast cells. The company develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases. Its stem cell-based therapy would provide treatment for an array of chronic degenerative diseases and in the regenerative repair of acute disease, such as trauma, infarction, and burns.

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
*********************************************************

The disclaimer is to be read and fully understood before using our site or joining our email list.
PLEASE NOTE WELL: StockStars.net and/or its affiliates are not registered as Investment Advisors in any jurisdiction whatsoever.
Release of Liability: Through use of StockStars.net email newsletter and website you agree to hold StockStars.net, its operators, owners, and employees harmless and completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. StockStars.net and/or its affiliates may from time to time have positions in the securities mentioned herein, may increase or decrease such positions without notice, and may profit from such transactions. StockStars.net has been compensated by a third party five thousand dollars for a one week MSOA advertising services contract. StockStars.net was previously compensated by the same third party five thousand dollars for MSOA advertising services. The third party may have shares and may liquidate, which may affect the stock’s price. Any opinions expressed are subject to change without notice. StockStars.net encourages readers and investors to supplement the information in these reports with independent research and other professional advice.
Please read our full disclaimer at http://www.stockstars.net/disclaimer.php.